NCT06394414 2025-02-24A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1 Recruiting162 enrolled